Case Study: Enabling Individualized Oncology Care at Community Hospitals
Download the Case Study here.
Expanding Virtual Maternity Services Using Video
With almost 4 million babies born in the United States each year, many people find themselves on an amazing journey to parenthood. However, the pregnancy journey and newborn experience can come with a lot of uncertainty and anxiety. In the eyes of new parents, there seem to be endless ways for things to go wrong yet never enough information and support.
When it’s day 10 of no sleep, these caretakers need somewhere to turn other than google. Endless searching down rabbit holes that contain contradicting information can cause even more stress. That’s where the power of maternity services comes in. A relationship built on trust, experience and understanding.
Health Comes First.
When it comes to their most prized possession, caretakers do not want to rely on a google article or book that was written 10 years ago. They want to talk to an actual person in their times of stress. Unlike books, these doulas, certified consultants and midwives are able to take in mind the individual circumstances of the mother and baby to craft a tailored approach to addressing sleep, nursing or even proper development.
Most doulas can attest they want to put the comfort, health and safety of their clients first. They would never want to unnecessarily spread germs or illnesses or add more stress by entering a new parent’s home when they are not ready to receive guests. In some cases such as the emergence of the Novel coronavirus, they may no longer be able to enter a home. Parents, even, are not able to take their child to a hospital for a consultation.
In any or all of these scenarios, it’s important to think about the power of an online visit to easily address the parents’ urgent needs. It’s also important to think about the impact of business revenue when in-person meetings are not allowed. It’s no longer just an option to meet virtually, but a business necessity.
Growing Relationships with Video.
Video calls are powerful in maternity services as they can cultivate a relationship for the caretaker that is convenient and ongoing. From an hour-long lactation consultation to a quick sleep question, your clients could reach you from anywhere and anytime. The video capability allows you to see any behaviors the caretaker is describing while also becoming a friendly face. There is also a level of comfort of a mother who can hop on her phone from the nursery or her laptop at the kitchen island.
Increase Your ROI.
In the current state of social distancing, doula agencies’ face-to-face revenue options are at a minimum, so using a video calling tool is crucial in allowing a new communication avenue that they can continue to monetize.
Since we won’t be in quarantine forever, video calling is also a great way to utilize employee downtime between appointments or labor and deliveries. It easily allows return business for quick questions.
But perhaps the most powerful reason to tap into the virtual options is that it gives any of these professionals the opportunity to expand their business beyond their geographic location. The lasting network that could be built from offering a virtual meeting could result in an added revenue stream even after reopening their in-person services and since Connect includes payment collection based on duration of call each interaction can be monetized.
Enable Video for Maternity Services with Connect.
LifeOmic Connect can power video and screenshare conversations for companies of any size. Implementation is simple, with most organizations able to field video calls via Connect for their organization on Day 0 of registration. Not only that, but Connect is customizable to align with your company’s brand experience.
Companies leveraging LifeOmic Connect can enable video across their entire site or limit to specific services such as lactation consulting or sleep training. These conversations can occur on-demand or pre-scheduled by leveraging the availability for each employee representative, allowing you to either capitalize on downtime or dedicate resources to help parents with their questions. Companies can also streamline the payment process by seamlessly integrating with Stripe that allows automatic payment collection for each call.
Isn’t it time to leverage the personalized experience and business expertise your team has built to better help your customers? Sign up today and make your knowledgeable staff available to help your customers and grow your customer loyalty.
Create Your Connect Account.
Make your business expertise available online, today.
GenomeWeb's Neil Versel gets an update on LifeOmic & the Indiana Precision Health Initiative
"Startup LifeOmic, which offers gene sequencing and related informatics technologies, is less than a year old, yet it seems poised to go where few health IT companies have gone before: aggregation and analysis of both clinical and omics data to support actual patient care."
See full GenomeWeb story Here (Premium Account Access required).
LifeOmic Leverages Genomenon’s Mastermind Genomic Search Engine for Variant Interpretation
For Immediate Release October 18, 2017
LifeOmic Partners with Genomenon to Streamline Genomic Interpretation of Whole Genomes
ANN ARBOR, Mich – October 18, 2017 – LifeOmic has signed an agreement with Genomenon to use the Mastermind Genomic Search Engine to streamline clinical interpretation of LifeOmic’s genome sequencing data. Through this partnership, LifeOmic will automate prioritization of their genome sequencing data for clinical patients by annotating disease-causing variants with citations from relevant biomedical literature. By providing immediate insight into published scientific literature, Mastermind speeds the variant interpretation process by helping scientists at LifeOmic decide which variants are likely associated with disease and important for clinical care and which are likely benign and can be safely ignored.
Dramatic advances in DNA sequencing technology hold great promise for personalized medicine, but challenges remain. As the cost and time associated with sequencing decrease, the industry is faced with the daunting challenge of how to store and analyze vast amounts of patient data to drive physicians’ decisions on diagnosis and treatment. LifeOmic has built a proprietary analytic platform with advanced informatics to process and analyze a patient’s whole genome to unlock the tremendous value hidden within this data.
Mastermind connects patients’ DNA mutations with citations from the scientific literature to understand the clinical impact of each mutation. Having indexed over 5.5 million scientific articles for every disease, gene and variant, Mastermind comprehensively identifies all clinically relevant and prioritized articles.
LifeOmic and Genomenon are co-presenting “Faster, Comprehensive Variant Curation For Whole Genome Sequencing” on Wednesday October 18th at the American Society of Human Genetics to formally announce their partnership. Tom Barber, CSO at LifeOmic, will present how LifeOmic is using DNA sequencing, big data analytics and Mastermind to advance the development of precision medicine.
About LifeOmic:
LifeOmic is a rapidly growing technology company pioneering the use of DNA sequencing and big data analytics to advance the development of precision medicine. The LifeOmic Precision Medicine PlatformTM is a secure cloud service for the long-term storage, retrieval, analysis and clinical use of genomic and other medical information. LifeOmic’s founder and CEO Don Brown, MD is one of Indiana’s most successful entrepreneurs. Dr. Brown founded two of the first three software companies in Indiana to be publicly traded on NASDAQ.
For more information, visit www.lifeomic.com.
About Genomenon:
Genomenon has eliminated the manual search process for gene and variant curation with its genomic search engine for use in clinical decision-making. By indexing millions of genomic-related scientific articles, Genomenon has created the only comprehensive genome-specific search engine to enable pathologists and geneticists to quickly and accurately curate disease-causing variants from genome sequence data.
For more information, visit www.genomenon.com or email sales@genomenon.com.
Press Contacts:
Genomenon: Jessica Francis 440.840.4987 or email jessicafrancisPR@gmail.com
LifeOmic: David Fuller 317.258.1031 or email David.Fuller@LifeOmic.com
IU, Regenstrief, LifeOmic Announce Collaboration to Revolutionize Medicine
INDIANAPOLIS – Indiana University, the Regenstrief Institute and Indianapolis-based technology company LifeOmic have announced a first-of-its kind collaboration to advance the development of precision medicine, a personalized approach to disease treatment and prevention.
Under terms of the agreement, LifeOmic receives a blanket license to a broad range of intellectual property owned by IU and Regenstrief as well as access to faculty. In return, IU and Regenstrief receive a minority equity position in LifeOmic. The strategic agreement will greatly facilitate collaboration across the three partners, removing traditional barriers between for-profit and not-for-profit organizations.
“Indiana University’s expertise in precision health research, combined with the Regenstrief Institute’s long history of innovation in medical records data and LifeOmic’s impressive capabilities in genomic data storage and management, make for a powerful partnership that will help our institutions collaborate to improve health in Indiana and beyond,” said IU President Michael A. McRobbie, PhD. “We look forward to seeing the discoveries that will stem from this alliance of academia and industry.”
The mapping of the human genome has made it possible to discover the underlying genetic causes of diseases in individuals and to tailor therapy based on that information. But the field of genomics also poses new challenges, as vast volumes of data must be analyzed, stored and incorporated into physicians’ decisions about diagnoses and treatments.
LifeOmic will work with scientists at IU and Regenstrief to develop a “data commons” to store genetic and other medical data for millions of patients within a single repository. The result will be a platform that can be used by researchers and clinicians around the state to make discoveries and improve the delivery of personalized health care.
The agreement also enables individual investigators at IU and Regenstrief to seamlessly collaborate with LifeOmic on other projects. For example, an IU immunologist might work with LifeOmic to develop a test to help physicians more efficiently and accurately diagnose autoimmune disorders. Such partnerships with industry are common but typically require separate, time-consuming negotiations for each project.
“The problems and challenges we are facing in health care today are too big to be solved by any one institution,” said Anantha Shekhar, MD, PhD, IU associate vice president of research for university clinical affairs and executive associate dean for research affairs at IU School of Medicine. “To make progress, we must collaborate with other universities and with private industry across multiple fields. My vision is to forge more industry partnerships like this with minimal bureaucratic barriers to collaborations, so we can tap into the expertise we need to serve patients in Indiana and elsewhere.”
Regenstrief President and CEO Peter J. Embi, MD, and LifeOmic founder and CEO Don Brown, MD, also praised the potential benefits for patients and the state of Indiana.
“The work we will do through this partnership will leverage all of our strengths and expertise to build systems that will support the future of health care,” Dr. Embi said. “We could not be more excited to work across our organizations to realize this vision and develop innovative systems that improve the health of people everywhere.”
“We’re excited to work with IU and Regenstrief to build a platform that can not only advance the delivery of precision medicine but serve as the basis for an entire ecosystem of health care innovation in Indiana,” Dr. Brown said. “We hope to see dozens of new companies spring up to take advantage of the tremendous opportunities ahead.”
About the collaborators
IU School of Medicine is the largest medical school in the United States and offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities. In June 2016, the school launched the Precision Health Initiative, the first of IU’s Grand Challenge research initiatives, with the goals of leveraging precision medicine to cure at least one cancer and one childhood disease, and to find ways to prevent one chronic illness and one neurodegenerative disease.
The Regenstrief Institute is a pioneer in health informatics, having developed many of the technologies and approaches that are now common across electronic health records and health information exchanges. Innovations developed at Regenstrief have helped make Indiana one of the most health-wired states in the country. Regenstrief Institute’s informatics experts and software engineers are actively working to build the infrastructure that will support incorporating genomic data and standards into electronic health record systems and routine health care.
LifeOmic is a rapidly growing technology company pioneering the use of DNA sequencing and big data analytics to advance the development of precision medicine. The LifeOmic Precision Medicine Platform™ is a secure cloud service for the long-term storage, retrieval, analysis and clinical use of genomic and other medical information. LifeOmic’s founder and CEO Don Brown, MD is one of Indiana’s most successful entrepreneurs. Dr. Brown founded two of the first three software companies ever to go public in Indiana – Software Artistry and Interactive Intelligence. Interactive Intelligence was acquired by Genesys Telecommunications Labs in 2016. At the time of the sale, Dr. Brown donated $30 million to the IU School of Medicine to found a new immunotherapy center to fight cancer and other diseases.
##
Media Contacts:
Andrea Zeek
317-278-2886
David Fuller
317-258-1031
Lisa Welch
317-274-9234